Search clinical trials for: AZD9833 with palbociclib
Total 17593 results
-
Peking University Cancer Hospital & InstituteKiang Wu HospitalUnknown
-
Samsung Medical CenterUnknownThymic CancerKorea, Republic of
-
University of Texas Southwestern Medical CenterUniversity of Pennsylvania; PfizerCompletedAdvanced Breast CancerUnited States
-
AstraZenecaCompleted
-
University of RochesterNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related DisordersUnited States
-
Hospital San Carlos, MadridCompleted
-
Novartis PharmaceuticalsCompleted
-
Institut BergoniéCompletedAdvanced Gastrointestinal Stromal TumorsFrance
-
UNC Lineberger Comprehensive Cancer CenterPfizerTerminatedMetastatic Urothelial Carcinoma (UC)United States
-
PfizerCompletedNeoplasms | Lymphoma, Non-HodgkinUnited States
-
UNICANCERPfizerActive, not recruitingSurgery | Breast Cancer Stage IV | RadiotherapyFrance
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer FemaleUnited States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdult Solid Tumor | HER2-positive Breast Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Germ Cell Tumor | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative... and other conditionsUnited States
-
GlaxoSmithKlinePfizerCompleted
-
TakedaTerminatedDiabetes MellitusUnited States
-
Latin American Cooperative Oncology GroupPfizerCompleted
-
Spanish Breast Cancer Research GroupAstraZenecaActive, not recruitingBreast NeoplasmsSpain, Ireland
-
Zhejiang Cancer HospitalPfizerRecruitingBreast NeoplasmsChina
-
Grupo Español de Investigación en NeurooncologíaPfizerCompleted
-
PfizerCompleted
-
Ascentage Pharma Group Inc.RecruitingBreast Cancer | Solid Tumor, AdultUnited States
-
Dana-Farber Cancer InstitutePfizer; Array BioPharmaActive, not recruiting
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
University of ArizonaPfizerCompletedBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | Recurrent Breast Cancer | HER2 Positive Breast Carcinoma | Breast Cancer StageUnited States
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Belarus, Bosnia and Herzegovina, Czechia, Hungary, Lithuania, Russian Federation, Serbia, Ukraine
-
Genentech, Inc.TerminatedBreast CancerUnited States, Korea, Republic of, Spain, Netherlands
-
International Cancer Research Group, United Arab...Pfizer; AstraZeneca; Genomic Health®, Inc.CompletedBreast Neoplasm FemaleUnited Arab Emirates, Algeria, Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, Tunisia
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA MutationUnited States, Spain, France, Italy
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Weill Medical College of Cornell UniversityRecruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...PfizerActive, not recruitingHCC | Advanced Hepatocellular Carcinoma | Liver CancerUnited States
-
TakedaCompleted
-
Asociatia Oncohelp - Centrul de Oncologie OncohelpMDX ResearchRecruitingMetastatic Breast CancerRomania
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
University GhentMerck Sharp & Dohme LLC; the Flanders Institute for BiotechnologyCompletedAxial SpondyloarthritisBelgium
-
Assistance Publique - Hôpitaux de ParisUnknownMelanoma BRAF V600E/K Mutated | CDNKN2A Loss DefinedFrance
-
Alliance Foundation Trials, LLC.Pfizer; Breast International Group; NSABP Foundation Inc; Austrian Breast & Colorectal... and other collaboratorsActive, not recruitingBreast CancerUnited States, Spain, Italy, Ireland, United Kingdom, Australia, Germany, Japan, Portugal, Taiwan, Canada, Israel, Netherlands, Switzerland, Belgium, Austria, Hungary, Korea, Republic of, Mexico, Poland, Sweden
-
Guangdong Provincial People's HospitalNot yet recruitingNeoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
-
Sun Yat-sen UniversityRecruiting
-
Weill Medical College of Cornell UniversityWithdrawn
-
AIPING ZHOURecruitingEsophagus Squamous Cell CarcinomaChina
-
Olema Pharmaceuticals, Inc.PfizerRecruiting
-
UNC Lineberger Comprehensive Cancer CenterPfizer; BioMed Valley Discoveries, IncRecruitingMelanoma | Pancreatic Cancer | Tumor, SolidUnited States
-
University of Michigan Rogel Cancer CenterCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
University of UlmPfizer; National Center for Tumor Diseases, HeidelbergUnknownAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaGermany
-
AstraZenecaCompletedNeoplasms | Breast Cancer | Metastatic CancerJapan
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Pfizer; The Leukemia and Lymphoma SocietyTerminatedRefractory Acute Leukemia | Relapsed Acute Leukemia | High-Risk MyelodysplasiaUnited States
-
PfizerActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Ovarian CancerUnited States, China, Japan, Mexico, Bulgaria, Argentina